ArticleFrontiers in oncology2025
Concurrent esophageal squamous cell carcinoma with gastric mucosa-associated lymphoid tissue lymphoma: a case report.
Article in Frontiers in oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Double primary malignant tumors are infrequently encountered, with esophageal squamous cell carcinoma (ESCC) co-occurring with malignancies in other organs, representing a rare clinical entity. The concomitant presence of ESCC and lymphoma is even more uncommon, posing substantial diagnostic and therapeutic challenges. Case demonstration: A 76-year-old Han Chinese man presented with dizziness, dysphagia, and vomiting. Computed tomography suggested a potential esophageal neoplasm. Gastroscopy identified an ulcerated esophageal mass, accompanied by altered gastric body morphology and branching changes. Histopathological examination of biopsied esophageal and gastric mucosa confirmed ESCC concurrently with gastric mucosa-associated lymphoid tissue (MALT) lymphoma. The patient declined surgical intervention and succumbed 13 months after diagnosis. Conclusions: The simultaneous occurrence of ESCC and gastric MALT lymphoma remains exceedingly rare. In ESCC cases, the potential for coexisting malignancies in the pharynx, stomach, or other sites warrants consideration. This report documents the first known case of ESCC coexisting with gastric MALT lymphoma, contributing to the current understanding of diagnosis and management strategies in lymphoma-associated ESCC cases.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.